Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Diagnostics

Premium
CombiMatrix Molecular Diagnostics last week launched its melanoma test, a diagnostic that it claims can discriminate malignant melanoma from benign moles.
 

The expression-based test, which runs on CombiMatrix’s CustomArray platform, could enable pathologists to resolve difficult-to-diagnose cases through an objective genetic analysis, CMDX parent CombiMatrix said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.